Reac%ve and Benign Flow Cytometry findings

Size: px
Start display at page:

Download "Reac%ve and Benign Flow Cytometry findings"

Transcription

1 Reac%ve and Benign Flow Cytometry findings Lymph nodes and other /ssues Sindhu Cherian, MD University of Washington, Sea<le

2 Flow cytometry Well established role in the diagnosis of hematopoie/c neoplasms characterized by expansion of a uniform popula/on of cells with a typical aberrant immunophenotype Lymphoma Acute leukemia

3 In some samples, the neoplas%c cell dominates Consider this biopsy of a colonic mass in a 70 year old man

4 Easy to make a diagnosis of B cell lymphoma: Mantle cell lymphoma But what do we make of the other B cells in this sample?

5 What about the T cells in this sample?

6 What about the T cells in this sample? CD4:CD8 ra%o of 1:2 Double nega%ve T cells with bright CD3 CD4+ T cells that express decreased CD7 CD8+ T cells with low to absent CD5

7 GOAL: By the end of this hour you will be able to recognize the significance of each of the highlighted lymphoid subsets

8 Objec%ves Characterize reac/ve popula/ons one may see in a variety of segngs Lymph nodes, /ssues Differen/ate normal reac/ve changes from neoplasms that may be present in these same sites Avoid missing a small abnormal popula/on Avoid calling a reac/ve finding neoplas/c Determine how recogni/on of reac/ve popula/ons in some cases may inform the diagnosis

9 Lymph node Harbor ~40% of all lymphocytes in humans ~2% in PB by comparison A reac/ve lymph node has many compartments that can be recognized by morphology Many of these popula/ons can also be recognized by flow cytometry Laane et al Clinical Cytometry 64B; Lazuardi et al Immunology 114 (37-43)

10 Reac%ve Lymph Node

11 Reac%ve Lymph node 25-50% B cells 50-75% T cells 5% NK cells

12 B cells (20-50%) CD5+ B cells Plasmacytoid B cells/plasma cells/plasmablasts Follicular hyperplasia Kappa:Lambda ra/o of 1.5-2:1

13 CD5+ B cells CD5 is expressed on pre naive B cells (CD10 and CD38 posi/ve) and a subset of naïve B cells (CD10 and CD38 nega/ve) Predominate in fetal circula/onà less frequent in adult circula/on ~10-15% of B cells in adult circula/on Greater numbers in spleen and circula/on than lymph node Increased in circula/on in some condi/ons: Autoimmune disease, marrow regenera/on, post transplant Polyclonal with normal expression of CD19 and CD20 allowing dis/nc/on from CD5+ B cell lymphomas (CLL, mantle cell) Perez-Andres et al. Cytometry part B 78B;S47-S60. Gupta et al. Am J Clin Pathol. 2004;121(3):

14 Plasmacyotoid B cells/plasma cells

15 Plasma cells/plasmacytoid B cells/ Plasmablasts Paracor/cal hyperplasia, non-specific IgG4 related lymphadenopathy Dis/nguish from: Plasmacytoid component of a B cell neoplasm (cytoplasmic light chain) Plasma cell neoplasm (cytoplasmic light chain, normal CD19 and CD45 without aberrant CD56)

16 Follicular hyperplasia

17 Follicular hyperplasia Non-specific (infec/on, inflammatory process) Dis/nguish from follicular lymphoma

18 Reac%ve Follicular Hyperplasia versus Follicular Lymphoma Usually reac/ve follicular hyperplasia is polyclonal allowing easy dis/nc/on of the two In some cases dis/nguishing between reac/ve florid follicular hyperplasia and follicular lymphoma can be a challenge Poten/al pihalls: Reac/ve follicular hyperplasia can down-regulate light chains Nega/ve light chain expression has been reported Zhao et al. AJCP 2005:123: Reac/ve follicular hyperplasia can be clonal ~1.1% of excisional biopsy specimens over a 5 year period Kussick et al, AJCP 2004;121:

19 Reac%ve follicular Follicular lymphoma hyperplasia CD10 Increased Increased CD20 Increased Increased CD19 Normal Decreased CD38 Increased Normal/Low BCL-2 Decreased Increased * Intensi/es are reported as compared to normal CD10 nega/ve B cells in a lymph node References: Mantei and Wood. Cytometry Part B. 2009;76B: Ray et al. AJCP. 2005;124: Cornfield at al. AJCP 2000;114:

20 Reac%ve follicular hyperplasia Follicular lymphoma Follicular lymphoma may have decreased CD19 expression CD38 is usually low in follicular lymphoma as compared to reac%ve follicular hyperplasia BCL-2 is over expressed in most cases of follicular lymphoma but nega%ve (below background B cells and T cells in reac%ve follicular hyperplasia.

21 T cells (50-75%) Express pan-t cell an/gens CD2 CD3 CD5 CD7 CD4:CD8 ra/o 2-5, fluctuates with different states Reac/ve changes are onen accompanied by an/genic shins Notable T cell subsets will be described in the next few slides T cell LGLs, γδ T cells, Memory T cells

22 Large Granular T Lymphocytes CD3+ T cells expressing CD8 with decreased CD5 CD57+, CD56+/-

23 Large Granular T Lymphocytes CD3+ T cells expressing CD8 with decreased CD5 CD57+, CD56+/- Reac/ve LGLs may in increased in lymph nodes infiltrated by tumor

24 Gamma Delta T cells Bright CD3+ T cells that are double nega/ve for CD4/CD8 or express low CD8

25 Gamma Delta T cells Bright CD3 + T cells that are double nega/ve for CD4/CD8 or express low CD8 More frequent in the spleen and intes/ne than in lymph nodes

26 Memory T cells CD4+ T cell subset with decreased CD7 Frequent in the skin, increased in inflammatory segngs May show increased CD2 expression Sanders et al. The Journal of Immunology (5):1401-7

27 CD56 expression on T cell subsets CD56 may be seen on a subset of CD4, CD8, dual posi/ve or dual nega/ve T cells CD56 expression is associated with enhanced cytotoxicity and cytokine secre/on (CD8+, DN) CD4+/CD8+/CD56+ clonal T cells may be increased in the blood in pa/ents with CMV CD4+/CD56+ T cells may be increased in some tumors Glioblastoma mul/forme Kelly-Rogers et al. Human Immunology. 2006;67: Waziri et al. The Journal of Immunology 2008;180: Rodriguez-Caballero et al. Blood. 2008;

28 Skewed CD4:CD8 ra%o HIV 0.7+/-0.1 Mantle cell lymphoma (<2) Higher CD4:CD8 ra/o be<er overall survival Reac/ve lymphoid hyperplasia (2-5) IgG4 associated lymph adenopathy ( ) Occasionally CD4/CD8 double posi/ve popula/ons are seen 1-6%) Dermatopathic lymphadenopathy (increased) Age related changes Increase in the CD4:CD8 ra/o due to decrease in CD8+ T cells Nygren et al. Clinical Cancer Research 20(23) Grimm et al. Modern Pathology ; Laane et al. Clinical Cytometry 2005;64B; Lazuardi et al. Immunology 2005;114: Tedla et al. Clinical experimental immunology 1999;117:92-99.

29 NK cells ( 5%) NK cells Typically express CD2 and CD7 without surface CD3 or CD5 Localize to the parafollicular region of the LN A subset may lack CD2 NK cells express CD56 and CD16 Intensity of these an/gens is typically reciprocal NK cells highlighted in blue, 1.2% of all lymphocytes

30 CD16 and CD56 on NK cells CD56 bright NK cells have low CD16 (bright CD7) Predominate in reac/ve lymph nodes (~90%) Minority of PB NK cells (~10%) CD16 bright T cells have lower CD56 Majority in PB (90-95%) and spleen (~85%) Fehniger et al. Blood. 2003;101(8): Ferlazzo et al. The Journal of Immunology. 2004;172:

31 Reac%ve changes can give rise to immunophenotypic changes resul%ng in a variety of T and NK cell subsets These reac%ve changes may overlap with the immunophenotype of some lymphomas Knowledge of the varia%on in normal is required to avoid over interpre%ng a reac%ve T or NK cell subset

32 The following features should raise your suspicion for T cell lymphoma Loss of or markedly decreased expression of CD45 Complete loss of one or more pan-t cell an/gens Decreased expression of more than 2 pan T cell an/gens in conjunc/on with altered light sca<er proper/es CD4/CD8 dual posi/ve or dual nega/ve popula/ons Exclusions Thymus Autoimmunelymphoprolifera/ve syndrome-alps Some reac/ve T cell subsets (either dual posi/ve or dual nega/ve) Gorczyca et al Clinical Cytometry ;

33 T cell lymphoma-ptcl No one change is completely specific for T cell lymphoma Abnormal T cell popula%ons iden%fied by flow cytometry must be interpreted in the appropriate clinical and morphologic context Increased sca<er proper/es Loss of more than one an/gen CD7 Surface CD3 Aberrant expression of other an/gens Decreased CD5 Increased CD4

34 The distribu%on of lymphoid cells may vary based on the anatomic site Other lymphoid organs: Spleen Thymus Non-lymphoid /ssues where lymphoid cells may reside Small intes/ne Skin

35 Spleen Largest lymphoid organ in the human (25% of total lymphocytes) B cells 40-50% Plasma cell/plasmacytoid lymphocyte 3-6% 8-11% CD5+ (decreased with age) T cells 30-50% CD4:8 ra/o 1.2 +/-3 Alpha beta 30-40% Gamma delta 2-5% ~15% NK cells Wide range More than blood or marrow Colovia et al. Modern pathology ;

36 Thymus Site of T cell development Full T cell matura/onal spectrum is present With thymic hyperplasia, thymoma, the dual posi/ve popula/on onen predominates, though single posi/ve and double nega/ve popula/ons are seen. Occasionally immature T cell popula/ons can be seen in reac/ve lymph nodes Castleman s disease

37 Skin Benign dermatoses can be associated with: Increase memory T cells CD3+ T cells that express CD4 without CD7 Increased CD4:CD8 ra/o Clonal T cell popula/ons

38 Small intes%ne Intes/nal lymphocytes typically express CD103 CD103 is expressed by 80-85% of lymphocytes in the intes/ne CD8+ T cells outnumber CD4+ T cells in this anatomic site: CD4:CD8 ra/o of ~1:2 May include a subset of CD5 nega/ve T cells May include a subset of CD56+ T cells Gamma delta T cells account for 5-10% of lymphocytes Rela/vely higher in pa/ents with small intes/nal bacterial overgrowth and celiac disease than in irritable bowel syndrome Included in the CD5- T cell subset Remes-Troche et al. Journal of Clinical Gastroenterology. 2007;41(7)

39 Jejunum-reac%ve lymphocytes 4:8 ra/o of 0.09 Gamma delta T cells are 7.5% of T cells CD8 low+ CD3 bright CD5 absent CD56 subset

40 With an understanding of the normal and reac%ve findings in various %ssues, you can understand and explain normal findings and differen%ate that from neoplasm

41 In addi%on, in some cases, recogni%on of reac%ve T cell popula%ons may inform the diagnosis In par%cular in situa%ons where the neoplas%c cell is a minor component of the infiltrate and an inflammatory background predominates.

42 Classical Hodgkin lymphoma Nodular lymphocyte predominant Hodgkin lymphoma T cell rich large B cell lymphoma As compared to non-specific reac%ve hyperplasia Increased T cells Decreased B cells Increased CD4:CD8 ra/o Wu et al Clinical Cytometry 2015 e-published ahead of press

43 Classical Hodgkin lymphoma Most studies show Increased propor/on of T cells Decreased propor/on of B cells Increased CD4:CD8 ra/o as compared to reac/ve hyperplasia Increased T regulatory cells (CD4 bright, CD25+) Surrogates CD3+/CD4+ T cells with bright CD45 and CD7 CD3+/CD4+ with CD38 without CD26 (seen in PB too) Hudnall et al. Clinical Cytometry B;1-8. Gaetano et al. Annals of Hematology ; Seegmiller et al. Clinical Cytometry B Wu et al Clinical Cytometry 2015 e-published ahead of press

44 Classical Hodgkin lymphoma Normal CHL Key plot: T cells

45 Nodular lymphocyte predominant Hodgkin lymphoma Several studies have demonstrated the presence of CD4+/CD8+ mature T cells in NLPHL Double posi/ve T cells accounted for 10-38% of all T cells in NLPHL (seen in ~60% of cases) 38% in progressively transformed germinal centers 4% reac/ve lymphoid hyperplasia 6% in classical Hodgkin lymphoma 10% or more double posi/ve T cells Sensi/vity 58.3% Specificity 96.2% Thought to represent an ac/vated or reac/ve T cell subset Didn t seem to be correlated with # of CD57+ cells by IHC; however, reac/ve double posi/ve T cell popula/ons are seen in inflammatory segngs and known to express CD57. Rahemtulla et al. AJCP 2006;126; Rahemtulla et al. Leukemia and Lymphoma (10)

46 Nodular lymphocyte predominant Hodgkin Lymphoma Key plot: T cells Normal NLPHL

47 T cell rich large B cell lymphoma High CD4:CD8 ra%o (15.2) Mature B cells are decreased (<5%) Increased CD45 and CD7 on CD4+ T cells Normal for comparison

48 Classical Hodgkin lymphoma CD4+ T cells with bright CD7 and CD45 (76.5%) Nodular lymphocyte predominant Hodgkin lymphoma Increased double CD4+/CD8+ cells 11.7% Compare to 2.18%; 3.70% T cell rich large B cell lymphoma CD4+ T cells with bright CD7 and CD45 (92.3%) Highest CD4:CD8 ra/o (~10) Compare to 4.18; 5.44 B cells are rare (~5%) Compare to 27.4%; 29.6% Wu et al Clinical Cytometry 2015 e-published ahead of press

49 What are the popula%ons highlighted in the case we started with? Plasmacytoid lymphocytes/ Plasma cells/plasmablasts Reac%ve follicular hyperplasia

50 What about the T cells in this sample? CD4:CD8 ra%o of 1:2 Double nega%ve T cells with bright CD3 Gamma delta T cells CD4+ T cells that express decreased CD7 Memory T cells CD8+ T cells with low to absent CD5 Large granular lymphocytes

51 Conclusions Understanding the immunophenotype of normal and of common reac/ve pa<erns will help Recognize abnormal popula/ons Prevent calling a reac/ve finding neoplas/c Furthermore, understanding reac/ve popula/ons may provide a clue to the true underlying diagnosis

52

Incidental Absolute Leukocytosis Connie Shen, MS2

Incidental Absolute Leukocytosis Connie Shen, MS2 Incidental Absolute Leukocytosis Connie Shen, MS2 Clinical History An otherwise healthy 73-year-old Caucasian man presents for a rou=ne physical. Review of systems is nega=ve. A CBC was obtained and reveals

More information

Immunopathology of Lymphoma

Immunopathology of Lymphoma Immunopathology of Lymphoma Noraidah Masir MBBCh, M.Med (Pathology), D.Phil. Department of Pathology Faculty of Medicine Universiti Kebangsaan Malaysia Lymphoma classification has been challenging to pathologists.

More information

Introduc)on to Immunology. T Cell Development

Introduc)on to Immunology. T Cell Development Introduc)on to Immunology T Cell Development Adolfo Ferrando af2196@columbia.edu Thymic stroma cells provide the microenvironment for T cell development. T cells develop from progenitors that are derived

More information

Flow cytometry for MRD detec1on: Focus on AML. Sindhu Cherian University of Washington, Sea6le, WA, USA

Flow cytometry for MRD detec1on: Focus on AML. Sindhu Cherian University of Washington, Sea6le, WA, USA Flow cytometry for MRD detec1on: Focus on AML Sindhu Cherian University of Washington, Sea6le, WA, USA Residual disease in hematopoie1c malignancy Residual disease has tradi:onal been defined by morphology

More information

JPEMS 2014 Basic Immunology module Activation and functions of T lymphocytes

JPEMS 2014 Basic Immunology module Activation and functions of T lymphocytes JPEMS 2014 Basic Immunology module Activation and functions of T lymphocytes Teacher: Pr. Régis Josien, Laboratoire d Immunologie, CHU Nantes Regis.Josien@univ-nantes.fr 1 An#gen recogni#on by T cells

More information

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk.

Mimics of Lymphoma in Routine Biopsies. I have nothing to disclose regarding the information to be reported in this talk. Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco I have nothing to disclose regarding the information to be reported in this

More information

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC

Lymphoma: What You Need to Know. Richard van der Jagt MD, FRCPC Lymphoma: What You Need to Know Richard van der Jagt MD, FRCPC Overview Concepts, classification, biology Epidemiology Clinical presentation Diagnosis Staging Three important types of lymphoma Conceptualizing

More information

Lymphoma and Myeloma Kris3ne Kra4s, M.D.

Lymphoma and Myeloma Kris3ne Kra4s, M.D. Lymphoma and Myeloma Kris3ne Kra4s, M.D. Hematologic Malignancies Leukemia Malignancy of hematopoie3c cells Starts in bone marrow, can spread to blood, nodes Myeloid or lymphoid Acute or chronic Lymphoma

More information

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia

Mimics of Lymphoma in Routine Biopsies. Mixed follicular and paracortical hyperplasia. Types of Lymphoid Hyperplasia Mimics of Lymphoma in Routine Biopsies Patrick Treseler, MD, PhD Professor of Pathology University of California San Francisco Types of Lymphoid Hyperplasia Follicular hyperplasia (B-cells) Paracortical

More information

Hematopathology Specialty Conference Case #1

Hematopathology Specialty Conference Case #1 Hematopathology Specialty Conference Case #1 Robert (Bob) Ohgami, MD, PhD Assistant Professor Stanford University Disclosure of Relevant Financial Relationships Disclosure of Relevant Financial Relationships

More information

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS

11/8/2018 DISCLOSURES. I have NO Conflicts of Interest to Disclose. UTILTY OF DETECTING PATTERNS Bharat N. Nathwani, M.D. City of Hope Medical Center Professor, Director of Pathology Consultation Services, 1500 East Duarte Road, Duarte, California, 91010 DISCLOSURES -------------------------------------------------------

More information

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies

Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Pearls and pitfalls in interpretation of lymphoid lesions in needle biopsies Megan S. Lim MD PhD University of Pennsylvania October 8, 2018 Objectives To understand how the trend toward less invasive lymph

More information

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour

7 Omar Abu Reesh. Dr. Ahmad Mansour Dr. Ahmad Mansour 7 Omar Abu Reesh Dr. Ahmad Mansour Dr. Ahmad Mansour -Leukemia: neoplastic leukocytes circulating in the peripheral bloodstream. -Lymphoma: a neoplastic process in the lymph nodes, spleen or other lymphatic

More information

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital

Differential diagnosis of hematolymphoid tumors composed of medium-sized cells. Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Differential diagnosis of hematolymphoid tumors composed of medium-sized cells Brian Skinnider B.C. Cancer Agency, Vancouver General Hospital Lymphoma classification Lymphoma diagnosis starts with morphologic

More information

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital

Lymphoma/CLL 101: Know your Subtype. Dr. David Macdonald Hematologist, The Ottawa Hospital Lymphoma/CLL 101: Know your Subtype Dr. David Macdonald Hematologist, The Ottawa Hospital Function of the Lymph System Lymph Node Lymphocytes B-cells develop in the bone marrow and influence the immune

More information

V. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach

V. Acute leukemia. Flow cytometry in evaluation of hematopoietic neoplasms: A case-based approach V. Acute leukemia Evaluating a sample for an acute leukemia Acute leukemia is a neoplasm of immature myeloid or lymphoid cells characterized by a block in maturation, usually at the stage of an early progenitor

More information

Follicular Lymphoma: the WHO

Follicular Lymphoma: the WHO Follicular Lymphoma: the WHO and the WHERE? Yuri Fedoriw, MD Associate Professor of Pathology and Laboratory Medicine Director of Hematopathology University of North Carolina Chapel Hill, NC Disclosure

More information

The spectrum of flow cytometry of the bone marrow

The spectrum of flow cytometry of the bone marrow The spectrum of flow cytometry of the bone marrow Anna Porwit Lund University Faculty of Medicine Dept. of Clinical Sciences Div. Oncology and Pathology anna.porwit@med.lu.se Disclosure of speaker s interests

More information

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport

From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology. Songlin Zhang, MD, PhD LSUHSC-Shreveport From Morphology to Molecular Pathology: A Practical Approach for Cytopathologists Part 1-Cytomorphology Songlin Zhang, MD, PhD LSUHSC-Shreveport I have no Conflict of Interest. FNA on Lymphoproliferative

More information

Case 3. Ann T. Moriarty,MD

Case 3. Ann T. Moriarty,MD Case 3 Ann T. Moriarty,MD Case 3 59 year old male with asymptomatic cervical lymphadenopathy. These images are from a fine needle biopsy of a left cervical lymph node. Image 1 Papanicolaou Stained smear,100x.

More information

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e

Pathology #07. Hussein Al-Sa di. Dr. Sohaib Al-Khatib. Mature B-Cell Neoplasm. 0 P a g e Pathology #07 Mature B-Cell Neoplasm Hussein Al-Sa di Dr. Sohaib Al-Khatib 0 P a g e Thursday 18/2/2016 Our lecture today (with the next 2 lectures) will be about lymphoid tumors This is a little bit long

More information

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8

Burkitt lymphoma. Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Heme 8 Burkitt lymphoma Sporadic Endemic in Africa associated with EBV Translocations involving MYC gene on chromosome 8 Most common is t(8;14) Believed to be the fastest growing tumor in humans!!!! Morphology

More information

Development of B and T lymphocytes

Development of B and T lymphocytes Development of B and T lymphocytes What will we discuss today? B-cell development T-cell development B- cell development overview Stem cell In periphery Pro-B cell Pre-B cell Immature B cell Mature B cell

More information

Test Utilization: Chronic Lymphocytic Leukemia

Test Utilization: Chronic Lymphocytic Leukemia Test Utilization: Chronic Lymphocytic Leukemia Initial Evaluation Diagnostic Criteria Selection of Tests for Prognosis Response to Therapy Challenges Assessment for persistent disease Paul J. Kurtin, M.D.

More information

T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma

T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma T cell lymphoma diagnostics and differential diagnosis to Hodgkin lymphoma Sylvia Hartmann Dr. Senckenberg Institute of Pathology Goethe University Frankfurt Overview Borderline ALCL classical HL Borderline

More information

88-year-old Female with Lymphadenopathy. Faizi Ali, MD

88-year-old Female with Lymphadenopathy. Faizi Ali, MD 88-year-old Female with Lymphadenopathy Faizi Ali, MD Clinical History A 88-year-old caucasian female presented to our hospital with the complaints of nausea, vomiting,diarrhea, shortness of breath and

More information

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO

HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA DR. ALEJANDRA ZARATE OSORNO HOSPITAL ESPAÑOL DE MEXICO HODGKIN LYMPHOMA CLASSIFICATION Lukes & Butler Rye WHO-2016 Linphocytic and/or histiocytic Nodular & diffuse Nodular Sclerosis Lymphocyte

More information

ACCME/Disclosures 4/13/2016. Clinical History

ACCME/Disclosures 4/13/2016. Clinical History ACCME/Disclosures The USCAP requires that anyone in a position to influence or control the content of CME disclose any relevant financial relationship WITH COMMERCIAL INTERESTS which they or their spouse/partner

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue Pathology of Hematopoietic and Lymphoid tissue Peerayut Sitthichaiyakul, M.D. Department of Pathology and Forensic Medicine Faculty of Medicine, Naresuan University CONTENTS White blood cells and lymph

More information

DETERMINATION OF A LYMPHOID PROCESS

DETERMINATION OF A LYMPHOID PROCESS Chapter 2 Applications of Touch Preparation Cytology to Intraoperative Consultations: Lymph Nodes and Extranodal Tissues for Evaluation of Hematolymphoid Disorders INTRODUCTION As discussed in Chap. 1,

More information

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU

Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Molecular Pathology of Lymphoma (Part 1) Rex K.H. Au-Yeung Department of Pathology, HKU Lecture outline Time 10:00 11:00 11:15 12:10 12:20 13:15 Content Introduction to lymphoma Review of lymphocyte biology

More information

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL)

Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Non-Hodgkin lymphomas (NHLs) Hodgkin lymphoma )HL) Lymphoid Neoplasms: 1- non-hodgkin lymphomas (NHLs) 2- Hodgkin lymphoma 3- plasma cell neoplasms Non-Hodgkin lymphomas (NHLs) Acute Lymphoblastic Leukemia/Lymphoma

More information

Contents. vii. Preface... Acknowledgments... v xiii

Contents. vii. Preface... Acknowledgments... v xiii Contents Preface... Acknowledgments... v xiii SECTION I 1. Introduction... 3 Knowledge-Based Diagnosis... 4 Systematic Examination of the Lymph Node... 7 Cell Type Identification... 9 Cell Size and Cellularity...

More information

Hepatic Lymphoma Diagnosis An Algorithmic Approach

Hepatic Lymphoma Diagnosis An Algorithmic Approach Hepatic Lymphoma Diagnosis An Algorithmic Approach Ryan M. Gill, M.D., Ph.D. University of California, San Francisco PLEASE TURN OFF YOUR CELL PHONES Disclosure of Relevant Financial Relationships USCAP

More information

Physiology Unit 3 THE SPECIFIC IMMUNE RESPONSE

Physiology Unit 3 THE SPECIFIC IMMUNE RESPONSE Physiology Unit 3 THE SPECIFIC IMMUNE RESPONSE The Adap4ve Arm of the Immune System Specific Immune Response Internal defense against a specific pathogen Acquired as you are exposed to diseases The immune

More information

Plasma cell myeloma (multiple myeloma)

Plasma cell myeloma (multiple myeloma) Plasma cell myeloma (multiple myeloma) Common lymphoid neoplasm, present at old age (70 years average) Remember: plasma cells are terminally differentiated B-lymphocytes that produces antibodies. B-cells

More information

Sponsored and reviewed by ICCS Quality and Standards Committee Title: Expression of CD5 on Normal Hematolymphoid Cells Written by:

Sponsored and reviewed by ICCS Quality and Standards Committee Title: Expression of CD5 on Normal Hematolymphoid Cells Written by: Sponsored and reviewed by ICCS Quality and Standards Committee Title: Expression of CD5 on Normal Hematolymphoid Cells Written by: Weina Chen and Buddy Frank Fuda Date: Jan 25, 2019 INTRODUCTION CD5 was

More information

T CELL LYMPHOMA ANALYSIS

T CELL LYMPHOMA ANALYSIS T CELL LYMPHOMA ANALYSIS Charles Goolsby, Ph.D. Floyd E. Patterson Research Professor of Pathology Northwestern Feinberg School of Medicine c-goolsby@northwestern.edu 1 T CELL LYMPHOMA ANALYSIS Diverse

More information

2012 by American Society of Hematology

2012 by American Society of Hematology 2012 by American Society of Hematology Common Types of HIV-Associated Lymphomas DLBCL includes primary CNS lymphoma (PCNSL) Burkitt Lymphoma HIV-positive patients have a 60-200 fold increased incidence

More information

Overview B cell development T cell development

Overview B cell development T cell development Topics Overview B cell development T cell development Lymphocyte development overview (Cont) Receptor diversity is produced by gene rearrangement and is random Includes specificities that will bind to

More information

Hematology Page 1 of 8

Hematology Page 1 of 8 Hematology Page 1 of 8 Hematology Major Category Code Headings Revised 12/17 1 Basic methodology and test armamentarium 20000 2 Normal hematopoiesis & hemostasis 20100 3 RBC disorders, non-neoplastic 20340

More information

Peripheral blood Pleural effusion in a cat

Peripheral blood Pleural effusion in a cat Tools for the Diagnosis of Lymphoproliferative Diseases When is it difficult to diagnose lymphoproliferative disease? Persistent lymphocytosis consisting of small Lymph node aspirates containing an excess

More information

Lymphoma and Pseudolymphoma

Lymphoma and Pseudolymphoma Lymphoma and Pseudolymphoma Laura B. Pincus, MD Co-Director, Cutaneous Lymphoma Clinic Associate Professor Dermatology and Pathology University of California, San Francisco I HAVE NO RELEVANT RELATIONSHIPS

More information

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009

CHAPTER:4 LEUKEMIA. BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY 8/12/2009 LEUKEMIA CHAPTER:4 1 BY Mrs. K.SHAILAJA., M. PHARM., LECTURER DEPT OF PHARMACY PRACTICE, SRM COLLEGE OF PHARMACY Leukemia A group of malignant disorders affecting the blood and blood-forming tissues of

More information

JMSCR Vol. 03 Issue 06 Page June 2015

JMSCR Vol. 03 Issue 06 Page June 2015 www.jmscr.igmpublication.org Impact Factor 3.79 ISSN (e)-2347-176x An Indolent Natural Killer Cell Leukemia Presenting with Bilateral Ankle Arthritis and Low Grade Fever Abstract Author Subhash Chandra

More information

Methods used to diagnose lymphomas

Methods used to diagnose lymphomas Institut für Pathologie Institut für Pathologie Methods used to diagnose lymphomas Prof. Dr.Med. Leticia Quintanilla-Fend Molecular techniques NGS histology Cytology AS-PCR Sanger seq. MYC Immunohistochemistry

More information

The Adaptive Immune Response. T-cells

The Adaptive Immune Response. T-cells The Adaptive Immune Response T-cells T Lymphocytes T lymphocytes develop from precursors in the thymus. Mature T cells are found in the blood, where they constitute 60% to 70% of lymphocytes, and in T-cell

More information

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008

MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA. April 16, 2008 MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS LYMPHOMA April 16, 2008 FACULTY COPY GOAL: Learn the appearance of normal peripheral blood elements and lymph nodes. Recognize abnormal peripheral blood

More information

B and T cell Memory. Bengt Lindbom Adap6ve Immunity BMC D14

B and T cell Memory. Bengt Lindbom Adap6ve Immunity BMC D14 B and T cell Memory Bengt Lindbom Adap6ve Immunity BMC D14 Immunity: a historical perspec6ve 430 B.C. Thucydides describes the ongoing plague of Athens:.the same man was never attacked twice 15th century:

More information

Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients

Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Hematopathology / LYMPHOMAS WITH IGM PARAPROTEIN Lymphoid Neoplasms Associated With IgM Paraprotein A Study of 382 Patients Pei Lin, MD, 1 Suyang Hao, MD, 1* Beverly C. Handy, MD, 2 Carlos E. Bueso-Ramos,

More information

Many of the hematolymphoid disorders are derived

Many of the hematolymphoid disorders are derived REVIEW ARTICLE Practical Immunohistochemistry in Hematopathology: A Review of Useful Antibodies for Diagnosis Ji Lu, MD and Karen L. Chang, MD Abstract: This review article offers some useful panels of

More information

Thomas Hodgkin and Hodgkin lymphoma

Thomas Hodgkin and Hodgkin lymphoma J Hematopathol (2014) 7:123 138 DOI 10.1007/s12308-014-0214-3 REVIEW ARTICLE Thomas Hodgkin and Hodgkin lymphoma Judith A. Ferry Received: 26 June 2014 /Accepted: 31 July 2014 /Published online: 12 August

More information

Nodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018

Nodular lymphocyte predominant Hodgkin lymphoma. Lymphoma Tumor Board. January 5, 2018 Nodular lymphocyte predominant Hodgkin lymphoma Lymphoma Tumor Board January 5, 2018 Etiology Subtypes of Classical Hodgkin Lymphoma (chl)* Nodular sclerosing HL Most common subtype Composed of large tumor

More information

Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma

Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma Daratumumab, a novel human CD38 monoclonal antibody for the treatment of B cell Non Hodgkin Lymphoma Anna Vidal Department of Hemato Oncology IDIBAPS, Barcelona, Spain B cell lymphoid malignancies seen

More information

Osteosclerotic Myeloma (POEMS Syndrome)

Osteosclerotic Myeloma (POEMS Syndrome) Osteosclerotic Myeloma (POEMS Syndrome) Osteosclerotic Myeloma (POEMS Syndrome) Synonyms Crow-Fukase syndrome Multicentric Castleman disease Takatsuki syndrome Acronym coined by Bardwick POEMS Scheinker,

More information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information

ADx Bone Marrow Report. Patient Information Referring Physician Specimen Information ADx Bone Marrow Report Patient Information Referring Physician Specimen Information Patient Name: Specimen: Bone Marrow Site: Left iliac Physician: Accession #: ID#: Reported: 08/19/2014 - CHRONIC MYELOGENOUS

More information

Lymphoma Read with the experts

Lymphoma Read with the experts Lymphoma Read with the experts Marc Seltzer, MD Associate Professor of Radiology Geisel School of Medicine at Dartmouth Director, PET-CT Course American College of Radiology Learning Objectives Recognize

More information

Small B-cell (Histologically Low Grade) Lymphoma

Small B-cell (Histologically Low Grade) Lymphoma Frequency of Lymphoid Neoplasms Small B-cell (Histologically Low Grade) Lymphoma Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital B-cell neoplasms 88% Diffuse large B-cell lymphoma

More information

FOLLICULARITY in LYMPHOMA

FOLLICULARITY in LYMPHOMA FOLLICULARITY in LYMPHOMA Reactive Follicular Hyperplasia Follicular Hyperplasia irregular follicles Follicular Hyperplasia dark and light zones Light Zone Dark Zone Follicular hyperplasia MIB1 Follicular

More information

Incidence. Bimodal age incidence 15-40, >55 years Childhood form (0-14) more common in developing countries M:F=1.5:1; in all subtypes except NS

Incidence. Bimodal age incidence 15-40, >55 years Childhood form (0-14) more common in developing countries M:F=1.5:1; in all subtypes except NS Hodgkin Lymphoma Hodgkin Lymphoma 30% of all lymphomas Absolute incidence unchanged Arise in lymph node, cervical region Neoplastic tissues usually contain a small number of tumor cells Incidence Bimodal

More information

PRECURSOR LYMHPOID NEOPLASMS. B lymphoblastic leukaemia/lymphoma T lymphoblastic leukaemia/lymphoma

PRECURSOR LYMHPOID NEOPLASMS. B lymphoblastic leukaemia/lymphoma T lymphoblastic leukaemia/lymphoma PRECURSOR LYMHPOID NEOPLASMS B lymphoblastic leukaemia/lymphoma T lymphoblastic leukaemia/lymphoma B lymphoblastic leukaemia/lymphoma Definition: B lymphoblastic leukaemia/lymphoma is a neoplasm of precursor

More information

Lymphocytoma Cutis. Cynthia M. Magro MD. Director of Dermatopathology Weill Medical College of Cornell University New York, New York

Lymphocytoma Cutis. Cynthia M. Magro MD. Director of Dermatopathology Weill Medical College of Cornell University New York, New York Lymphocytoma Cutis Cynthia M. Magro MD Professor of Pathology Director of Dermatopathology Weill Medical College of Cornell University New York, New York Lymphocytoma Cutis Falls under other designations

More information

Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure

Patterns of Lymphoid Neoplasia in Peripheral Blood. Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Patterns of Lymphoid Neoplasia in Peripheral Blood Leon F. Baltrucki, M.D. Leon F. Baltrucki, M.D. Disclosure Dr Baltrucki has received an honorarium for his participation as a faculty presenter in this

More information

The Lymphomas. An overview..

The Lymphomas. An overview.. The Lymphomas An overview.. Peter Anglin MD, FRCPC, MBA Stronach Regional Cancer Centre Newmarket, ON The lymphomas are an important part of the history of medicine 1666 Magpighi publishes first recorded

More information

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester

Bone marrow morphology in reactive conditions. Kaaren K. Reichard, MD Mayo Clinic Rochester Bone marrow morphology in reactive conditions Kaaren K. Reichard, MD Mayo Clinic Rochester reichard.kaaren@mayo.edu Nothing to disclose Conflict of Interest Outline of Presentation Brief introduction General

More information

Hematology 101. Rachid Baz, M.D. 5/16/2014

Hematology 101. Rachid Baz, M.D. 5/16/2014 Hematology 101 Rachid Baz, M.D. 5/16/2014 Florida 101 Epidemiology Estimated prevalence 8,000 individuals in U.S (compare with 80,000 MM patients) Annual age adjusted incidence 3-8/million-year 1 More

More information

B cell activation and antibody production. Abul K. Abbas UCSF

B cell activation and antibody production. Abul K. Abbas UCSF 1 B cell activation and antibody production Abul K. Abbas UCSF 2 Lecture outline B cell activation; the role of helper T cells in antibody production Therapeutic targeting of B cells 3 Principles of humoral

More information

The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D.

The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. The Development of Lymphocytes: B Cell Development in the Bone Marrow & Peripheral Lymphoid Tissue Deborah A. Lebman, Ph.D. OBJECTIVES 1. To understand how ordered Ig gene rearrangements lead to the development

More information

3/23/2017. Disclosure of Relevant Financial Relationships. Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?!

3/23/2017. Disclosure of Relevant Financial Relationships. Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?! Pitfalls in Immunohistochemistry in Hematopathology: CD20 and CD3 Can Let Me Down?! Judith A. Ferry Massachusetts General Hospital Disclosure of Relevant Financial Relationships USCAP requires that all

More information

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals

Understanding your diagnosis. Dr Graham Collins Consultant Haemtologist Oxford University Hospitals Understanding your diagnosis Dr Graham Collins Consultant Haemtologist Oxford University Hospitals Common questions I get asked What is lymphoma? What subtype do I have and what does that mean? What are

More information

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital

Immunohistochemical classification of haematolymphoid tumours. Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital Immunohistochemical classification of haematolymphoid tumours Stephen Hamilton-Dutoit Institute of Pathology Aarhus University Hospital Malignant lymphoproliferative diseases What are they? Haematolymphoid

More information

Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014

Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014 Q&A Session Collecting Cancer Data: Hematopoietic and Lymphoid Neoplasms Thursday, November 6, 2014 Q: If polycythemia ruba vera (PRV) or essential thrombocythemia (ET) is diagnosed by peripheral smear,

More information

Update in Lymphoma Imaging

Update in Lymphoma Imaging Update in Lymphoma Imaging Victorine V. Muse, MD Lymphoma Update in Lymphoma Imaging Victorine V Muse, MD Heterogeneous group of lymphoid neoplasms divided into two broad histological categories Hodgkin

More information

Integrated Hematopathology. Morphology and FCI with IHC

Integrated Hematopathology. Morphology and FCI with IHC Integrated Hematopathology Morphology and FCI with IHC FrontMatter.indd i 9/6/2009 9:30:12 PM FrontMatter.indd ii 9/6/2009 9:30:18 PM Integrated Hematopathology Morphology and FCI with IHC Cherie H Dunphy,

More information

Abstracting Hematopoietic Neoplasms

Abstracting Hematopoietic Neoplasms CASE 1: LYMPHOMA PHYSICAL EXAMINATION 43yo male with a history of lower gastrointestinal bleeding and melena undergoing colonoscopy and biopsy to rule out neoplasm versus inflammation. Patient had no other

More information

Lymphoma: The Basics. Dr. Douglas Stewart

Lymphoma: The Basics. Dr. Douglas Stewart Lymphoma: The Basics Dr. Douglas Stewart Objectives What is lymphoma? How common is it? Why does it occur? How do you diagnose it? How do you manage it? How do you follow patients after treatment? What

More information

Approach to Core Biopsy Specimens

Approach to Core Biopsy Specimens BDIAP 108th Symposium on Haematopathology Joint Meeting of the BDIAP and BLPG at-bristol, Anchor Road, Harbourside, Bristol BS1 5DB 15th - 17th May 2014 Approach to Core Biopsy Specimens Dr Stefan Dojcinov

More information

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98

Presentation material is for education purposes only. All rights reserved URMC Radiology Page 1 of 98 Presentation material is for education purposes only. All rights reserved. 2011 URMC Radiology Page 1 of 98 Radiology / Pathology Conference February 2011 Brooke Koltz, Cytopathology Resident Presentation

More information

Pathology of Hematopoietic and Lymphoid tissue

Pathology of Hematopoietic and Lymphoid tissue CONTENTS Pathology of Hematopoietic and Lymphoid tissue White blood cells and lymph nodes Quantitative disorder of white blood cells Reactive lymphadenopathies Infectious lymphadenitis Tumor metastasis

More information

Lymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco

Lymphoma Update: Lymphoma Update: What s Likely to be New in the New WHO. Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What s Likely to be New in the New WHO Blood 127:2375; 2016 Patrick Treseler, MD, PhD University of California San Francisco Lymphoma Update: What IS New in the New WHO! Patrick Treseler,

More information

Case Workshop of Society for Hematopathology and European Association for Haematopathology

Case Workshop of Society for Hematopathology and European Association for Haematopathology Case 148 2007 Workshop of Society for Hematopathology and European Association for Haematopathology Robert P Hasserjian Department of Pathology Massachusetts General Hospital Boston, MA Clinical history

More information

Persistent lymphocytosis. Persistent lymphocytosis: are there prognostic indicators? Problem. Questions. Basic markers used to identify lymphocytes

Persistent lymphocytosis. Persistent lymphocytosis: are there prognostic indicators? Problem. Questions. Basic markers used to identify lymphocytes Persistent lymphocytosis Persistent lymphocytosis: are there prognostic indicators? Paul R. Avery VMD, PhD, DACVP Marjorie Williams, DVM Anne C. Avery VMD, PhD Clinical Immunology Laboratory Colorado State

More information

COURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12

COURSE: Medical Microbiology, MBIM 650/720 - Fall TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 COURSE: Medical Microbiology, MBIM 650/720 - Fall 2008 TOPIC: Antigen Processing, MHC Restriction, & Role of Thymus Lecture 12 FACULTY: Dr. Mayer Office: Bldg. #1, Rm B32 Phone: 733-3281 Email: MAYER@MED.SC.EDU

More information

Classification of Hematologic Malignancies. Patricia Aoun MD MPH

Classification of Hematologic Malignancies. Patricia Aoun MD MPH Classification of Hematologic Malignancies Patricia Aoun MD MPH Objectives Know the basic principles of the current classification system for hematopoietic and lymphoid malignancies Understand the differences

More information

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory

The development of clonality testing for lymphomas in the Bristol Genetics Laboratory. Dr Paula Waits Bristol Genetics Laboratory The development of clonality testing for lymphomas in the Bristol Genetics Laboratory Dr Paula Waits Bristol Genetics Laboratory Introduction The majority of lymphoid malignancies belong to the B cell

More information

VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping

VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping VENTANA hematopathology solutions Comprehensive aids for detecting and subtyping 1 12/4/2015 9:47:24 AM 2 Hematopathology diagnostic solutions Contents VENTANA hematopathology assays 3 Detecting and subtyping

More information

Mantle Cell Lymphoma

Mantle Cell Lymphoma HEMATOPATHOLOGY Original Article Mantle Cell Lymphoma Morphologic Findings in Bone Marrow Involvement JAY WASMAN, MD, 1 NANCY S. ROSENTHAL, MD,' AND DIANE C. FARHI, MD 2 Although mantle cell lymphoma (MCL),

More information

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell?

Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? Abbas Chapter 2: Sarah Spriet February 8, 2015 Question 1. Kupffer cells, microglial cells and osteoclasts are all examples of what type of immune system cell? a. Dendritic cells b. Macrophages c. Monocytes

More information

Critical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry

Critical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry Hematopathology / FLOW CYTOMETRIC IMMUNOPHENOTYPING IN B-CELL NON-HODGKIN LYMPHOMA Critical Analysis and Diagnostic Usefulness of Limited Immunophenotyping of B-Cell Non-Hodgkin Lymphomas by Flow Cytometry

More information

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University

Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms. Daniel A. Arber, MD Stanford University Integrated Diagnostic Approach to the Classification of Myeloid Neoplasms Daniel A. Arber, MD Stanford University What is an integrated approach? What is an integrated approach? Incorporating all diagnostic

More information

Bone marrow T-cell infiltrates in viral infections and autoimmune diseases Alexander Tzankov

Bone marrow T-cell infiltrates in viral infections and autoimmune diseases Alexander Tzankov Bone marrow T-cell infiltrates in viral infections and autoimmune diseases Alexander Tzankov Institute of Pathology, University Hospital Basel Bone marrow T-cell infiltrates Physiological roles of mature

More information

Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms

Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms J Hematopathol (2009) 2:65 73 DOI 10.1007/s12308-009-0034-z COMMENT Commentary on the 2008 WHO classification of mature T- and NK-cell neoplasms Megan S. Lim & Laurence de Leval & Leticia Quintanilla-Martinez

More information

Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders

Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders Primary Cutaneous CD30-Positive T-cell Lymphoproliferative Disorders Definition A spectrum of related conditions originating from transformed or activated CD30-positive T-lymphocytes May coexist in individual

More information

ABERRANT EXPRESSION OF CD19 AND CD43

ABERRANT EXPRESSION OF CD19 AND CD43 ABERRANT EXPRESSION OF CD19 AND CD43 IN A PATIENT WITH THERAPY-RELATED ACUTE MYELOID LEUKEMIA AND A HISTORY OF MANTLE CELL LYMPHOMA Yen-Chuan Hsieh, 1 Chien-Liang Lin, 2 Chao-Jung Tsao, 2 Pin-Pen Hsieh,

More information

Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY

Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY A Somewhat Different View of the Gene3c Portrait of Chronic Lymphocy3c Leukemia Nicholas Chiorazzi The Feinstein Ins3tute for Medical Research Northwell Health Manhasset, NY Acknowledgments Davide Bagnara

More information

Pathology of the Lymphoid System

Pathology of the Lymphoid System Pathology of the Lymphoid System Learning Objectives: Define lymphadenitis and enumerate its types. Briefly describe the morphological appearance of reactive lymph node. Describe the microscopic picture

More information

Diagnosis of lymphoid neoplasms has been

Diagnosis of lymphoid neoplasms has been Iranian Journal of Pathology (2007)2 (1), 1-61 Review Article Mehdi Nassiri Dep. of Pathology, University of Miami Miller School of Medicine, Miami, USA Abstract Correct diagnosis and classification of

More information

Non-Hodgkin s Lymphomas Version

Non-Hodgkin s Lymphomas Version NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Non-Hodgkin s Lymphomas Version 2.2015 NCCN.org Continue Use of Immunophenotyping/ Genetic Testing in Differential Diagnosis of Mature B-Cell

More information

CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting

CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Original Article DOI: 10.21276/APALM.1364 CD5 Positive Follicular Lymphomas- A Diagnostic Dilemma in a Resource Restricted Laboratory Setting Sakthi Sankari S 1 *, Arjunan A 2, Bhuvaneswari M.G. 2, Sindhuja

More information

5/1/13. The proportion of thymus that produces T cells decreases with age. The cellular organization of the thymus

5/1/13. The proportion of thymus that produces T cells decreases with age. The cellular organization of the thymus T cell precursors migrate from the bone marrow via the blood to the thymus to mature 1 2 The cellular organization of the thymus The proportion of thymus that produces T cells decreases with age 3 4 1

More information